Radiology-Today-CT-FFR-Keya-Medical

Keya Medical at SCCT 25 Global in Amsterdam – Booth 14

Keya Medical will showcase the application of Deep Learning CT-derived Fractional Flow Reserve analysis and upcoming advanced AI-driven solutions in non-invasive cardiac diagnostics. Visit Booth 14 at SCCT 2025 Global in Amsterdam.

Dr. Irfan Shafique to Present on AI-Driven CT FFR at SCCT Global Meeting 2025.

The Society of Cardiovascular Computed Tomography (SCCT) Global Meeting 2025 in Amsterdam brings together top experts in cardiovascular CT from around the world. Among the distinguished speakers is Dr. Irfan Shafique, MD, who will present on February 7, 2025, at 8:00 am, during an industry session hosted by Keya Medical. His presentation will focus on the application of artificial intelligence (AI) in CT-derived Fractional Flow Reserve (CTFFR) analysis. Dr. Shafique’s session will highlight Keya Medical’s advanced AI solutions and their potential to enhance the accuracy and efficiency of non-invasive cardiac diagnostics.

Industry Session
Friday, 7 February
8:40 – 8:50 CET
Keya Medical: AI in CTFFR analysis
Irfan Shafique, MD

About Dr. Irfan Shafique

Dr. Irfan Shafique, MD, is a renowned radiologist with extensive expertise in cardiac imaging. He is one of the pioneers of cardiac CTA imaging and training programs and courses at Johns Hopkins Bayview Medical Center. He is a former Johns Hopkins faculty member and co-directed cardiac CT training practicum, and he continues to teach the CME course. This most popular cardiac CT training practicum has been running for over 20 years. He has served and led many companies as CEO and CMO and serves on advisory boards (Cardiac America, Healthcare Imaging, Brexa, and Forward Healthcare Consultants).

Dr.Shafique is currently with Chesapeake Medical Imaging overseeing the Cardiac Imaging program. With a solid foundation in internal medicine and cardiology, Dr. Shafique completed postgraduate training in nuclear medicine at Johns Hopkins Medical Institutions (JHMI) in Baltimore, Maryland, and further training in radiology in Washington, DC. He is board-certified in Radiology, Nuclear Medicine, and Nuclear Cardiology and Cardiac CT.

About DEEPVESSEL FFR

DEEPVESSEL FFR is a software medical device that uses deep learning technology to perform a non-invasive physiological functional assessment of the coronary arteries using coronary computed tomography angiography (CCTA). The software processes coronary CTA images semi-automatically, generates a three-dimensional model of the coronary artery tree, and estimates CT FFR values. DEEPVESSEL FFR is FDA-Cleared, CE-Marked, NMPA-Cleared, HSA-Certified.

About Keya Medical

Keya Medical is an international medical technology company developing deep learning-based medical devices for disease diagnosis and treatment. The company is committed to creating solutions that deliver clinical value at all stages in the patient care process, covering specialties including cardiology, neurology, pulmonology, pathology, and surgery. Keya Medical has four centers of excellence in Beijing, Shanghai, Shenzhen, and Seattle. Follow us on LinkedIn, Twitter, and Facebook.

Media Contact
contact@keyamedna.com

Learn more about DEEPVESSEL FFR

We are actively looking for clinical partners in the United States and EMEA.